Sterzyńska, K.; Klejewski, A.; Wojtowicz, K.; Świerczewska, M.; Andrzejewska, M.; Rusek, D.; Sobkowski, M.; Kędzia, W.; Brązert, J.; Nowicki, M.;
et al. The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines. Int. J. Mol. Sci. 2018, 19, 2901.
https://doi.org/10.3390/ijms19102901
AMA Style
Sterzyńska K, Klejewski A, Wojtowicz K, Świerczewska M, Andrzejewska M, Rusek D, Sobkowski M, Kędzia W, Brązert J, Nowicki M,
et al. The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines. International Journal of Molecular Sciences. 2018; 19(10):2901.
https://doi.org/10.3390/ijms19102901
Chicago/Turabian Style
Sterzyńska, Karolina, Andrzej Klejewski, Karolina Wojtowicz, Monika Świerczewska, Małgorzata Andrzejewska, Damian Rusek, Maciej Sobkowski, Witold Kędzia, Jacek Brązert, Michał Nowicki,
and et al. 2018. "The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines" International Journal of Molecular Sciences 19, no. 10: 2901.
https://doi.org/10.3390/ijms19102901
APA Style
Sterzyńska, K., Klejewski, A., Wojtowicz, K., Świerczewska, M., Andrzejewska, M., Rusek, D., Sobkowski, M., Kędzia, W., Brązert, J., Nowicki, M., & Januchowski, R.
(2018). The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines. International Journal of Molecular Sciences, 19(10), 2901.
https://doi.org/10.3390/ijms19102901